Wednesday, December 18, 2024

Latest:

Mapping functional relations among proteins and genes helps illuminate their role in cancer
Occupational therapy: what patients need to know
Holly jolly health tips for Santa (and you)
Championing better care for adolescents with iron deficiency: Highlighting the impact of quality improvement initiatives
SPACe: A new open-source platform that supports large imaging data analysis on standard computers

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Langerhans cell histiocytosis

A promising two-punch therapy for Langerhans cell histiocytosis

June 29, 2021 dendritic cells, Langerhans cell histiocytosis, MAPK inhibitor, PD-1 receptors, rare cancer, Research, T-cell exhaustion

A novel combination therapy resulted in a significant decrease of disease burden in an animal model of LCH.

From The Labs

The 2019 Michael E. DeBakey M.D. Awards for Excellence in Research

May 16, 2019 2019 DeBakey research awards, Batten disease, C. difficile, heart attack, Langerhans cell histiocytosis, lysosomal storage disorders, Neurodegeneration, NIH Roadmap Epigenomics, Research, trehalose, tropinin

The 2019 Michael E. DeBakey M.D. Award for Research Excellence ceremony honored five Baylor College of Medicine faculty members for their excellence in published scientific

From the Labs: Humans are complex genetic mosaics.